Tremfya Overdosage

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Overdosage

Single intravenous doses of Guselkumab (Tremfya) up to 987 mg (10 mg/kg) have been administered in healthy volunteers and single subcutaneous doses of Guselkumab (Tremfya) up to 300 mg have been administered in subjects with plaque psoriasis in clinical trials without dose-limiting toxicity. In the event of overdosage, monitor the patient for any signs or symptoms of adverse reactions and administer appropriate symptomatic treatment immediately.

guselkumab

Manufacturer:

Cilag AG

Distributor:

Johnson & Johnson